Revision history of "Randomised Controlled trial with Pravastatin versus placebo for Prevention of preeclampsia (STATIN trial)" (Q3138701)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 06:4106:41, 4 August 2022DG Regio talk contribs 58,593 bytes +39,246 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 09:3909:39, 2 December 2021DG Regio talk contribs 13,340 bytes +1,893 Created claim: summary (P836): OBJECTIF: Examiner si l’utilisation prophylactique de l’Utrogestan vaginal à partir du premier triméster de la grossesse chez les femmes ayant une grossesse jumelle peut réduire l’incidence de l’accouchement spontané avant 34 semaines. MÉTHODES: Essai contrôlé randomisé à double aveugle de phase III à deux bras pour examiner l’effet de la pravastatine prophylactique à partir de 35 à 37 semaines de gestation chez les femmes à risque accru d’EP-t...
  • curprev 09:3909:39, 2 December 2021DG Regio talk contribs 11,447 bytes +178 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 13:1913:19, 12 October 2021DG Regio talk contribs 11,269 bytes +165 Changed label, description and/or aliases in en: translated_label
  • curprev 13:1913:19, 12 October 2021DG Regio talk contribs 11,104 bytes +1,717 Created claim: summary (P836): OBJECTIVE: To examine if the prophylactic use of vaginal Utrogestan from the first-trimester of pregnancy in women with twin pregnancy can reduce the incidence of spontaneous delivery before 34 weeks. METHODS: Phase III two-arm double-blinded randomised controlled trial to examine the effect of prophylactic pravastatin from 35-37 weeks’ gestation in women at increased risk for term-PE on the incidence and severity of the disease PRIMARY OUTCOME...

10 October 2021

9 October 2021

7 October 2021